CN108949845B - Fermentation medium and method for preparing mupirocin from fermentation medium - Google Patents
Fermentation medium and method for preparing mupirocin from fermentation medium Download PDFInfo
- Publication number
- CN108949845B CN108949845B CN201810896368.9A CN201810896368A CN108949845B CN 108949845 B CN108949845 B CN 108949845B CN 201810896368 A CN201810896368 A CN 201810896368A CN 108949845 B CN108949845 B CN 108949845B
- Authority
- CN
- China
- Prior art keywords
- percent
- culture medium
- fermentation
- mupirocin
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 97
- 230000004151 fermentation Effects 0.000 title claims abstract description 97
- MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 title claims abstract description 49
- 229960003128 mupirocin Drugs 0.000 title claims abstract description 48
- 229930187697 mupirocin Natural products 0.000 title claims abstract description 48
- DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 title claims abstract description 48
- 238000000034 method Methods 0.000 title claims abstract description 24
- 239000001963 growth medium Substances 0.000 claims abstract description 96
- 230000001580 bacterial effect Effects 0.000 claims abstract description 74
- 239000002609 medium Substances 0.000 claims abstract description 57
- 238000011218 seed culture Methods 0.000 claims abstract description 53
- 238000012258 culturing Methods 0.000 claims abstract description 45
- 239000007788 liquid Substances 0.000 claims abstract description 43
- 241000589516 Pseudomonas Species 0.000 claims abstract description 28
- 241000589540 Pseudomonas fluorescens Species 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 42
- 239000000843 powder Substances 0.000 claims description 34
- 239000002518 antifoaming agent Substances 0.000 claims description 24
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 22
- 239000008103 glucose Substances 0.000 claims description 22
- 239000008223 sterile water Substances 0.000 claims description 21
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 12
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 12
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 12
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 12
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 239000001888 Peptone Substances 0.000 claims description 8
- 108010080698 Peptones Proteins 0.000 claims description 8
- 235000019319 peptone Nutrition 0.000 claims description 8
- 238000012807 shake-flask culturing Methods 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims description 7
- 229920001817 Agar Polymers 0.000 claims description 6
- 239000008272 agar Substances 0.000 claims description 6
- 229960003237 betaine Drugs 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000007952 growth promoter Substances 0.000 claims description 5
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- 244000068988 Glycine max Species 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 239000003549 soybean oil Substances 0.000 claims description 4
- 235000012424 soybean oil Nutrition 0.000 claims description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 239000010703 silicon Substances 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 235000019483 Peanut oil Nutrition 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 2
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 229940041514 candida albicans extract Drugs 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 2
- 239000000312 peanut oil Substances 0.000 claims description 2
- 150000003017 phosphorus Chemical class 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 239000012138 yeast extract Substances 0.000 claims description 2
- 229960003136 leucine Drugs 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 abstract description 8
- 230000035764 nutrition Effects 0.000 abstract description 8
- 230000004060 metabolic process Effects 0.000 abstract description 6
- 230000002503 metabolic effect Effects 0.000 abstract description 2
- 239000011259 mixed solution Substances 0.000 description 12
- 230000001954 sterilising effect Effects 0.000 description 12
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 239000007787 solid Substances 0.000 description 5
- 238000001816 cooling Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 241000606768 Haemophilus influenzae Species 0.000 description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 description 2
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 241000193996 Streptococcus pyogenes Species 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229940047650 haemophilus influenzae Drugs 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 238000010953 Ames test Methods 0.000 description 1
- 231100000039 Ames test Toxicity 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000006311 Pyoderma Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003248 enzyme activator Substances 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- MINDHVHHQZYEEK-HBBNESRFSA-N mupirocin Chemical compound C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-HBBNESRFSA-N 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 206010033072 otitis externa Diseases 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
- C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810896368.9A CN108949845B (en) | 2018-08-08 | 2018-08-08 | Fermentation medium and method for preparing mupirocin from fermentation medium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810896368.9A CN108949845B (en) | 2018-08-08 | 2018-08-08 | Fermentation medium and method for preparing mupirocin from fermentation medium |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108949845A CN108949845A (en) | 2018-12-07 |
CN108949845B true CN108949845B (en) | 2021-08-10 |
Family
ID=64468948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810896368.9A Active CN108949845B (en) | 2018-08-08 | 2018-08-08 | Fermentation medium and method for preparing mupirocin from fermentation medium |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108949845B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110468051B (en) * | 2019-07-31 | 2022-08-23 | 海正药业(杭州)有限公司 | K252A fermentation medium and preparation method thereof |
CN111996136A (en) * | 2020-07-24 | 2020-11-27 | 北大方正集团有限公司 | Pseudomonas fluorescens fermentation medium, culture method and application |
US20240043888A1 (en) * | 2021-02-07 | 2024-02-08 | Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. | Fermentation method for mupirocin |
CN113274346A (en) * | 2021-05-25 | 2021-08-20 | 满孝勇 | Application of mupirocin ointment |
CN115873718B (en) * | 2022-10-25 | 2024-08-16 | 江苏神华药业有限公司 | Liquid fermentation medium for armillaria mellea mycelium and preparation method and application thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1354798A (en) * | 1999-02-03 | 2002-06-19 | 拜奥盖尔药厂有限公司 | Process for preparation of pseudomonic acid A antibiotic by microbiological method |
WO2003000910A2 (en) * | 2001-06-21 | 2003-01-03 | Biogal Gyogyszergyar Rt | Metabolic controlled fermentation process for pseudomonic acid production |
CN102453740A (en) * | 2011-12-15 | 2012-05-16 | 宁夏多维药业有限公司 | Culture medium for producing vitamin B12 by fermenting pseudomonas denitrificans and fermentation method thereof |
CN102719504A (en) * | 2012-07-04 | 2012-10-10 | 潍坊祥维斯化学品有限公司 | Vitamin B12 complex fermenting addition agent and application method thereof to fermenting vitamin B12 |
CN105039271A (en) * | 2015-06-25 | 2015-11-11 | 山东祥维斯生物科技有限公司 | Method for increasing yield of various enzyme preparations |
CN107384984A (en) * | 2017-09-05 | 2017-11-24 | 安徽曦萌生物工程有限公司 | A kind of method that fermentation method improves citrin QQ yield |
CN108277243A (en) * | 2018-01-19 | 2018-07-13 | 浙江瑞邦药业股份有限公司 | A kind of preparation method of Pseudomonic Acid A |
-
2018
- 2018-08-08 CN CN201810896368.9A patent/CN108949845B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1354798A (en) * | 1999-02-03 | 2002-06-19 | 拜奥盖尔药厂有限公司 | Process for preparation of pseudomonic acid A antibiotic by microbiological method |
WO2003000910A2 (en) * | 2001-06-21 | 2003-01-03 | Biogal Gyogyszergyar Rt | Metabolic controlled fermentation process for pseudomonic acid production |
CN102453740A (en) * | 2011-12-15 | 2012-05-16 | 宁夏多维药业有限公司 | Culture medium for producing vitamin B12 by fermenting pseudomonas denitrificans and fermentation method thereof |
CN102719504A (en) * | 2012-07-04 | 2012-10-10 | 潍坊祥维斯化学品有限公司 | Vitamin B12 complex fermenting addition agent and application method thereof to fermenting vitamin B12 |
CN105039271A (en) * | 2015-06-25 | 2015-11-11 | 山东祥维斯生物科技有限公司 | Method for increasing yield of various enzyme preparations |
CN107384984A (en) * | 2017-09-05 | 2017-11-24 | 安徽曦萌生物工程有限公司 | A kind of method that fermentation method improves citrin QQ yield |
CN108277243A (en) * | 2018-01-19 | 2018-07-13 | 浙江瑞邦药业股份有限公司 | A kind of preparation method of Pseudomonic Acid A |
Non-Patent Citations (2)
Title |
---|
甜菜碱的生产方法及应用;张兰峰等;《生物技术世界》;20121231(第54期);第28页3.5 * |
莫匹罗星的菌种选育与发酵工艺的研究;杨行正;《中国优秀硕士学位论文全文数据库 工程科技I辑》;20130215;第39页3,第42页-43页5,第52页3.4 * |
Also Published As
Publication number | Publication date |
---|---|
CN108949845A (en) | 2018-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108949845B (en) | Fermentation medium and method for preparing mupirocin from fermentation medium | |
Pradhan et al. | Solubilization of inorganic phosphates by fungi isolated from agriculture soil | |
CN108641996B (en) | Fermentation medium of bacillus licheniformis and production method thereof | |
CN108026546A (en) | Microbacterium bacterial strain is used for the purposes for producing antiseptic | |
CN109722408B (en) | Method for promoting bacillus subtilis to produce spores | |
US5434060A (en) | Method for producing ε-poly-L-lysine | |
JPH03130084A (en) | Production of trehalose | |
CN106591401B (en) | Fermentation promoter for increasing yield of gentamicin C1a and addition method thereof | |
RU2665830C1 (en) | Mutant strain corynebacterium glutamicum, producing l-glutamine (options), and a method for producing l-glutamine | |
CN103014092A (en) | Preparation method for improving productivity of mitomycin C | |
RU2675503C1 (en) | Method of obtaining biological preparation for stimulation of growth and protection of plants against diseases | |
CN110923180A (en) | Bacillus megaterium liquid high-density fermentation medium and supplementary culture method thereof | |
KR100801143B1 (en) | Method for culturing of mixture of bacillus polyfermenticus and saccharomyces cerevisiae | |
FI65084C (en) | NYTT FOERFARANDE FOER FRAMSTAELLNING AV ANTIBIOTIKUMET SISOMICIN | |
CN113214274B (en) | Octahydrofuran [2,3-b ] pyridine-4, 6-diol, and preparation method and application thereof | |
CN114634903B (en) | Directional activation method of beneficial flora in soil and application of yeast lysate in lactic acid bacteria growth promotion | |
CN116606780B (en) | Pseudomonas bacteria NJAU-T129 and application thereof | |
KR102071861B1 (en) | Bacteria having increased extracellular polysaccharide and method for cultivating the same | |
CN102660493A (en) | Trichoderma sporulation medium and sporulation method | |
KR101781782B1 (en) | Medium composition for the production of Rhodobacter sphaeroides KNU-04 comprising N-Acylhomoserine lactone as an active ingredient | |
CN109504729B (en) | Fermentation method of vancomycin | |
CN109913503B (en) | Method for producing tetraene compound by utilizing streptomyces albidoflauvs Ah11601 | |
El-Waseif et al. | Biosynthesis, optimization and structure elucidation of antimicrobial agent produced by Streptomyces clavuligerus isolated from Egyptian soil. | |
CN105779535A (en) | Culture medium for fermenting and producing enramycin and fermentation method | |
CN106480136A (en) | A kind of preparation method of ribostamycin fermentation liquid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a fermentation medium and a method for preparing mupirocin from the fermentation medium Effective date of registration: 20220420 Granted publication date: 20210810 Pledgee: Fujian Straits bank Limited by Share Ltd. Fuqing branch Pledgor: FUJIAN KANGHONG BIOTECHNOLOGY Co.,Ltd. Registration number: Y2022350000042 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230413 Granted publication date: 20210810 Pledgee: Fujian Straits bank Limited by Share Ltd. Fuqing branch Pledgor: FUJIAN KANGHONG BIOTECHNOLOGY Co.,Ltd. Registration number: Y2022350000042 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A fermentation medium and a method for preparing mupirocin from the fermentation medium Effective date of registration: 20230418 Granted publication date: 20210810 Pledgee: Fujian Straits bank Limited by Share Ltd. Fuqing branch Pledgor: FUJIAN KANGHONG BIOTECHNOLOGY Co.,Ltd. Registration number: Y2023350000121 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20210810 Pledgee: Fujian Straits bank Limited by Share Ltd. Fuqing branch Pledgor: FUJIAN KANGHONG BIOTECHNOLOGY Co.,Ltd. Registration number: Y2023350000121 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A fermentation medium and a method for preparing mupirocin from fermentation medium Granted publication date: 20210810 Pledgee: Fujian Straits bank Limited by Share Ltd. Fuqing branch Pledgor: FUJIAN KANGHONG BIOTECHNOLOGY Co.,Ltd. Registration number: Y2024350000040 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |